According to the recent study the artificial pancreas device system market is projected to reach an estimated $XX billion by 2028 from $XX billion in 2023, at a CAGR of 13% to 15% from 2023 to 2028. Growth in this market is primarily driven by increasing prevalence of diabetes, rising demand for insulin self-administration, and rising demand for automated systems for glycemic control. Browse XX figures / charts and XX tables in this 150 -page report to understand trends, opportunities and forecast in artificial pancreas device system market by product (threshold suspend device systems, control- to-range systems (CTR), and control-to- target systems (CTT)), end use industry (hospitals, medical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World). Download sample report by clicking on below link https://www.lucintel.com/artificial-pancreas-device-system-market.aspx “Threshold suspend device systems market is expected to remain the largest segment during the forecast period.” Based on product, the artificial pancreas device system market is segmented into threshold suspend device systems, control- to-range systems (CTR), and control-to- target systems (CTT). Lucintel forecasts that the threshold suspend device systems market is expected to remain the largest segment due to the actions taken automatically when the patient is unable to respond to threshold suspend alarm and stops insulin delivery when the value of sensor glucose reaches a low threshold. “Within the artificial pancreas device system market, the hospitals segment is expected to remain the largest end use industry” Based on end use industry the hospitals segment is expected to witness the highest growth over the forecast period due to because it contains some of the most efficiently planned referral networks for responding adequately to the population's health needs. “North America will dominate the artificial pancreas device system market in near future” North America will remain the largest region due to the growing awareness about advanced technologies in diabetes management, high prevalence of obesity, as well as presence of major players in the region, and the presence of efficient reimbursement policies. Download Brochure of this report by clicking on https://www.lucintel.com/artificial-pancreas-device-system-market.aspx Major players of artificial pancreas device system market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Medtronic, Bigfoot Biomedical, Johnson & Johnson, Dexcom, Tandem Diabetes Care, Pancreum Inc., TypeZero Technologies, Beta Bionics, and F. Hoffmann-La Roche are among the major artificial pancreas device system providers. This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/artificial-pancreas-device-system-market.aspx or helpdesk@lucintel.com
